EVOLVING CONCEPTS OF PARTIAL AGONISM - THE BETA-ADRENERGIC-RECEPTOR AS A PARADIGM

[1] ABRAMSON SN, 1985, J BIOL CHEM, V260, P4580

[2] FUNCTIONAL-GROUPS, DRUG RECEPTOR INTERACTIONS AND DRUG DESIGN [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (04) : 148 - 151

[3] BENOVIC JL, 1988, J BIOL CHEM, V263, P2893

[4] BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675

[5] DRUGS FROM EMASCULATED HORMONES - THE PRINCIPLE OF SYNTOPIC ANTAGONISM [J]. SCIENCE, 1989, 245 (4917) : 486 - 493

[6] BOEYNAEMS JM, 1980, OUTLINES RECEPTOR TH

[7] BRANDT DR, 1986, J BIOL CHEM, V261, P1656

[8] CHEUNG AH, 1989, MOL PHARMACOL, V34, P132

[9] CONTRERAS ML, 1986, J PHARMACOL EXP THER, V237, P154

[10] STRUCTURAL FEATURES REQUIRED FOR LIGAND-BINDING TO THE BETA-ADRENERGIC-RECEPTOR [J]. EMBO JOURNAL, 1987, 6 (11) : 3269 - 3275

[1] ABRAMSON SN, 1985, J BIOL CHEM, V260, P4580

[2] FUNCTIONAL-GROUPS, DRUG RECEPTOR INTERACTIONS AND DRUG DESIGN [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (04) : 148 - 151

[3] BENOVIC JL, 1988, J BIOL CHEM, V263, P2893

[4] BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675

[5] DRUGS FROM EMASCULATED HORMONES - THE PRINCIPLE OF SYNTOPIC ANTAGONISM [J]. SCIENCE, 1989, 245 (4917) : 486 - 493

[6] BOEYNAEMS JM, 1980, OUTLINES RECEPTOR TH

[7] BRANDT DR, 1986, J BIOL CHEM, V261, P1656

[8] CHEUNG AH, 1989, MOL PHARMACOL, V34, P132

[9] CONTRERAS ML, 1986, J PHARMACOL EXP THER, V237, P154

[10] STRUCTURAL FEATURES REQUIRED FOR LIGAND-BINDING TO THE BETA-ADRENERGIC-RECEPTOR [J]. EMBO JOURNAL, 1987, 6 (11) : 3269 - 3275